The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder

  title={The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder},
  author={Stephen V. Faraone},
  journal={European Child \& Adolescent Psychiatry},
  • S. Faraone
  • Published 1 February 2005
  • Psychology
  • European Child & Adolescent Psychiatry
Continued questioning of the validity of a diagnosis of attention-deficit/hyperactivity disorder (ADHD) has created uncertainties about its management in the minds of many clinicians and the public. Inaccurate beliefs about the validity of ADHD hinder the clinical care of many ADHD patients and lead to confusion about the need to seek out or accept treatment. Critics describe ADHD as a diagnosis used to label difficult children who are not ill but whose behavior is at the extreme end of normal… 

Delay of attention deficit hyperactivity disorder diagnosis in France - reasons and resolutions

Adequate diagnosis and treatment of ADHD are needed to improve not only ADHD core symptoms, but also social, academic and familial functioning and the use of evidence-based criteria to improve the reliability and validity of diagnosis.

Attention-Deficit Hyperactivity Disorder in Adults and Children: ADHD diagnostic and symptom assessment scales for adults

Although the diagnostic criteria for attention-deicit hyperactivity disorder (ADHD) were originally intended for children [1, 2], the criteria are the same for adults and can be reliably used to

ADHD symptomatology is best conceptualized as a spectrum: a dimensional versus unitary approach to diagnosis

A case is built for the utility of conceptualizing ADHD, not as a unitary disorder that contains several subtypes, but rather as a marker of impairment in attention and/or impulsivity that can be used to identify one of several disorders belonging to a spectrum.

Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD)

This article reviews rating instruments that have found general acceptance and discusses instruments that focus on functional impairment, quality of life, comorbid disorders, gender effects and specific psychopathological models.

Attention deficit hyperactivity disorder: a lifespan genetic perspective

It is concluded that ADHD is a lifespan condition that shares genetic risk factors with other psychiatric, neurodevelopmental disorders and intellectual disabilities and the case is made that clinicians working in the area of intellectual disability should be fully aware of the potential impact of ADHD.

Current status of cognitive-behavioral therapy as a psychosocial treatment for adult attention-deficit/hyperactivity disorder

  • J. Ramsay
  • Psychology
    Current psychiatry reports
  • 2007
The status of cognitive-behavioral therapy (CBT) as an effective psychosocial treatment (when combined with pharmacotherapy) for adult ADHD is reviewed.

Psychosocial Treatments for Attention-Deficit/Hyperactivity Disorder in Adults: Current Evidence and Future Directions

Summary and Limitations of Psychosocial TreatmentStudies To date, the aforementioned researchers have laid an initialempirical foundation for the benefit of psychosocial treatments foradult ADHD.

Substance use among ADHD adults: implications of late onset and subthreshold diagnoses.

Data about late onset ADHD provides further support for the idea that the DSM-IV age at onset criterion is too stringent, and subthreshold ADHD seems to be a milder form of the disorder, or perhaps a heterogeneous group of true ADHD cases and false positives.



The worldwide prevalence of ADHD: is it an American condition?

Analysis of the available data suggests that the prevalence of ADHD is at least as high in many non-US children as in US children, with the highest prevalence rates being seen when using DSM-IV diagnoses.

Attention-deficit/hyperactivity disorder in adults: an overview

Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms.

Assessment of the influence of overlapping symptoms on the diagnosis of ADHD shows that ADHD is not an artifact of symptoms shared with other psychiatric disorders and that the comorbid conditions themselves are not an artifacts of overlapping ADHD symptoms.

Pediatricians' knowledge and attitudes concerning diagnosis and treatment of attention deficit and hyperactivity disorders. A national survey approach.

Findings indicate that methylphenidate (Ritalin) hydrochloride is the most prescribed medication for treatment of ADD and ADHD.

DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents.

The results support the decision to subdivide the heterogeneous category of DSM-III-R attention deficit hyperactivity disorder into three subtypes and the resulting DSM-IV definition appears to be somewhat less biased toward the symptom pattern typical of elementary school boys.

Efficacy of Adderall® for Attention-Deficit/Hyperactivity Disorder: A meta-analysis

Data from the six available studies of standard release Adderall show it to be efficacious for symptoms of inattention, hyperactivity- impulsivity, and aggression, as well as global ratings.